Table 2 Clinical diagnoses of SUD patients
SUD patients | ||
|---|---|---|
Reference (n = 4 436) | Physicians (n = 133) | |
Years of clinical SUD diagnosis between 2011 and 2016 (mean (SD)) | 1.7 (1.1) | 1.7 (1.1) |
Substance of abuse or dependence (n (%)) | ||
Alcohol | 3 357 (75.7) | 90 (67.7) |
Amphetamine | 112 (2.5) | * |
Cannabis | 779 (17.6) | 14 (10.5) |
Cocaine | 387 (8.7) | 7 (5.3) |
Opioid | 150 (3.4) | * |
Sedative, hypnotic, or anxiolytic | 302 (6.8) | 22 (16.5) |
Other or unknown substance(s) | 177 (4.0) | 10 (7.5) |
Comorbid psychiatric disorder (n (%)) | ||
Developmental disorder | 372 (8.4) | 10 (7.5) |
Cognitive disorder | 53 (1.2) | * |
Psychotic disorder | 196 (4.4) | * |
Mood disorder | 1 177 (26.5) | 42 (31.6) |
Anxiety disorder | 626 (14.1) | 15 (11.3) |
Somatoform and/or dissociative disorder | 91 (2.1) | 6 (4.5) |
Personality disorder | 1 100 (24.8) | 37 (27.8) |
Other psychiatric disorder | 650 (14.7) | 15 (11.3) |
Somatic comorbidity (n (%)) | ||
Complex | 350 (7.9) | 13 (9.8) |
Singular | 791 (17.8) | 24 (18.0) |
Start score Global Assessment of Functioning (n (%)) | ||
Constant danger to major impairment (0–40) | 391 (8.8) | 9 (6.8) |
Serious to moderate symptoms (41–60) | 3220 (72.6) | 95 (71.4) |
Mild to no symptoms (61–100) | 681 (15.4) | 23 (17.3) |
End score Global Assessment of Functioning (n (%)) | ||
Persistent danger to major impairment (0–40) | 334 (7.5) | 6 (4.5) |
Serious to moderate symptoms (41–60) | 2435 (54.9) | 66 (49.6) |
Mild to no symptoms (61–100) | 1476 (33.3) | 53 (39.8) |